US Archives - Page 53 of 130 - European Medical Journal

Dermatologic Risks for Polar Explorers in Arctic and Antarctic Missions

Dermatological conditions in polar environments are gaining new attention as research missions to the Arctic and Antarctic expand.

How Rheumatologists Choose Specialists to Refer To

Understanding referral patterns in rheumatic disease management is crucial to improving interdisciplinary care and patient outcomes.

Phase III Pembrolizumab Trial in Head and Neck Cancer: AACR 2025

Patients with newly diagnosed, locally advanced head and neck squamous cell carcinoma (HNSCC) may soon benefit from a major shift in treatment strategy, as phase III trial data show that perioperative pembrolizumab significantly improves outcomes when added to standard care.

Emerging Technologies Challenge Orthopedic Infection Norms

The targeted use of local antibiotics in orthopedic surgery is gaining traction, but limited supporting evidence continues to challenge its widespread adoption, according to a new review exploring current practices and novel technologies in infection management.

Could This Berry Compound Help Protect the Aging Brain?

In a new randomized controlled trial, daily anthocyanin supplementation significantly improved inflammation and cardiometabolic biomarkers in older adults at risk for dementia, a finding that may have implications for both brain and cardiovascular health.

Exclusive E-Cigarette Use Linked to Lung and Blood Pressure Risks

A new longitudinal study from the All of Us Research Program sheds light on the potential cardiometabolic consequences of exclusive e-cigarette use and dual tobacco use in adults across the United States.

Inside the Hidden Threat of CNS Infections After Kidney Transplant

New 20-year study reveals that rare CNS infections in kidney transplant recipients carry high mortality and long-term neurological impact, with metagenomic sequencing crucial for diagnosis.

Pediatric Pulmonary Embolism More Common Than Once Thought

Pulmonary embolism in children may be more prevalent than previously recognized according to new findings from a large prospective multicenter study conducted across 21 pediatric emergency departments in the United States.

AMJ Dermatology 2 [Supplement 3] 2025

In this new article, discover recent clinical insights on clascoterone cream 1% and its potential role in addressing excess sebum…

Spotlight on Sebum Production

A recent study found that clascoterone cream 1% significantly reduces sebum production in patients with mild-to-moderate acne, suggesting…